PUBLIC DISCLOSURE & CLARIFICATION

BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.

CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.

Acyclovir liposomes

Inquiry

Cat. No.: X26-05-ZQ1916

Acyclovir liposomes

Name: Acyclovir liposomes
SKU: X26-05-ZQ1916

Inquiry

Synonym: Acyclovir LPs; Acyclovir-loaded liposomes; Acyclovir liposomal formulations

Product Size

100 mg; 250 mg; 500 mg; 1 g; 5 g

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

This formulation features acyclovir liposomes engineered to encapsulate a synthetic purine nucleoside analogue within a stable vesicle matrix. The structural matrix incorporates the compound acyclovir within the central aqueous core and polar headgroup interfacial regions of a high-purity phospholipid bilayer, utilizing a precise lipid-to-cholesterol ratio to maximize entrapment efficiency. This configuration protects the nucleoside structure from premature chemical precipitation and controls passive drug leakage across the lipid membrane interface under ambient laboratory conditions.

Source

Custom synthesis

Functional Group

Acyclovir

Form

Solid or powder

Purity

≥95%

Impurities

No visible impurities to the naked eye.

Identity

HPLC/MS/NMR

Publications

Publications (0)

Publications

×

Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.